Xbrane Resubmit the BLA for Ranibizumab Biosimilar to Treat Serious Eye Disease
July 4, 2022
Samsung Bioepis & Celltrion Report Results of CT-P13 and SB2 (biosimilar, infliximab) in Prospective Study for the Treatment of In...
May 28, 2022
Alvotech Resolved European Patent Dispute with AbbVie for AVT02 (biosimilar, adalimumab)
April 6, 2022
Samsung Bioepis’s Ontruzant (biosimilar, trastuzumab) Receives the Health Canada Approval for the Treatment of Breast & Gastric Ca...
February 2, 2022
Xbrane Biopharma Seeks to Initiate the Development of Keytruda and Darzalex Biosimilar
December 13, 2021
Amgen Seeks Interchangeable Status for Its Amjevita (biosimilar, adalimumab)
November 8, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.